Published in Nat Struct Biol on October 01, 1999
Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. J Cell Biol (2000) 5.71
Structural characterization of the human respiratory syncytial virus fusion protein core. Proc Natl Acad Sci U S A (2000) 2.58
Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions. J Virol (2003) 2.31
Small molecules that bind the inner core of gp41 and inhibit HIV envelope-mediated fusion. Proc Natl Acad Sci U S A (2006) 1.83
Short constrained peptides that inhibit HIV-1 entry. Proc Natl Acad Sci U S A (2002) 1.77
Potent D-peptide inhibitors of HIV-1 entry. Proc Natl Acad Sci U S A (2007) 1.76
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope. Proc Natl Acad Sci U S A (2005) 1.74
Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion. J Virol (2000) 1.58
Inhibiting HIV fusion with a beta-peptide foldamer. J Am Chem Soc (2005) 1.55
Restraining the conformation of HIV-1 gp120 by removing a flexible loop. EMBO J (2006) 1.41
Point mutations in EBV gH that abrogate or differentially affect B cell and epithelial cell fusion. Virology (2007) 1.39
Structural and functional analysis of interhelical interactions in the human immunodeficiency virus type 1 gp41 envelope glycoprotein by alanine-scanning mutagenesis. J Virol (2001) 1.38
Neutralization of infectivity of diverse R5 clinical isolates of human immunodeficiency virus type 1 by gp120-binding 2'F-RNA aptamers. J Virol (2003) 1.37
Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates. Proc Natl Acad Sci U S A (2010) 1.36
Crystal structure and size-dependent neutralization properties of HK20, a human monoclonal antibody binding to the highly conserved heptad repeat 1 of gp41. PLoS Pathog (2010) 1.36
Mutations of Epstein-Barr virus gH that are differentially able to support fusion with B cells or epithelial cells. J Virol (2005) 1.34
Design of a potent D-peptide HIV-1 entry inhibitor with a strong barrier to resistance. J Virol (2010) 1.33
Targeting a binding pocket within the trimer-of-hairpins: small-molecule inhibition of viral fusion. Proc Natl Acad Sci U S A (2004) 1.30
The core of the respiratory syncytial virus fusion protein is a trimeric coiled coil. J Virol (2000) 1.29
Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein. Proc Natl Acad Sci U S A (2009) 1.14
The trimer-of-hairpins motif in membrane fusion: Visna virus. Proc Natl Acad Sci U S A (2001) 1.13
HIV envelope: challenges and opportunities for development of entry inhibitors. Trends Microbiol (2011) 1.13
The role of medical structural genomics in discovering new drugs for infectious diseases. PLoS Comput Biol (2009) 1.11
HIV entry inhibitors and their potential in HIV therapy. Med Res Rev (2009) 1.04
Plucking the high hanging fruit: a systematic approach for targeting protein-protein interactions. Bioorg Med Chem (2012) 1.03
Evaluation of "credit card" libraries for inhibition of HIV-1 gp41 fusogenic core formation. J Comb Chem (2006) 0.95
Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein. J Virol (2003) 0.91
Site-directed antibodies against the stem region reveal low pH-induced conformational changes of the Semliki Forest virus fusion protein. J Virol (2006) 0.89
Broad distribution of energetically important contacts across an extended protein interface. J Am Chem Soc (2011) 0.88
Identification of a beta3-peptide HIV fusion inhibitor with improved potency in live cells. Bioorg Med Chem Lett (2009) 0.87
Design of an engineered N-terminal HIV-1 gp41 trimer with enhanced stability and potency. Protein Sci (2008) 0.87
Protease-resistant peptide design-empowering nature's fragile warriors against HIV. Biopolymers (2012) 0.86
Amphipathic properties of HIV-1 gp41 fusion inhibitors. Curr Top Med Chem (2011) 0.84
Compatibility of the gH homologues of Epstein-Barr virus and related lymphocryptoviruses. J Gen Virol (2007) 0.84
High-Throughput HIV-Cell Fusion Assay for Discovery of Virus Entry Inhibitors. Assay Drug Dev Technol (2015) 0.79
Mechanisms for HIV-1 Entry: Current Strategies to Interfere with This Step. Curr Infect Dis Rep (2001) 0.78
Approaches for identification of HIV-1 entry inhibitors targeting gp41 pocket. Viruses (2013) 0.78
Single-chain protein mimetics of the N-terminal heptad-repeat region of gp41 with potential as anti-HIV-1 drugs. Proc Natl Acad Sci U S A (2014) 0.78
Inhibition of HIV Entry by Targeting the Envelope Transmembrane Subunit gp41. Curr HIV Res (2016) 0.77
Computer applications for prediction of protein-protein interactions and rational drug design. Adv Appl Bioinform Chem (2009) 0.77
Comparison of predicted scaffold-compatible sequence variation in the triple-hairpin structure of human imunodeficiency virus type 1 gp41 with patient data. J Virol (2002) 0.77
Efficient trapping of HIV-1 envelope protein by hetero-oligomerization with an N-helix chimera. Retrovirology (2005) 0.76
Blocking HIV entry. Nat Struct Biol (1999) 0.76
Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41. Curr Top Med Chem (2016) 0.75
Constrained peptides as miniature protein structures. ISRN Biochem (2012) 0.75
Picture story. Keeping HIV out. Nat Struct Biol (1999) 0.75
Screening and Functional Profiling of Small-Molecule HIV-1 Entry and Fusion Inhibitors. Assay Drug Dev Technol (2017) 0.75
Site-specific Isopeptide Bridge Tethering of Chimeric gp41 N-terminal Heptad Repeat Helical Trimers for the Treatment of HIV-1 Infection. Sci Rep (2016) 0.75
Battling AIDS. Nat Struct Biol (1999) 0.75
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature (1981) 24.17
Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem (2000) 19.03
Atomic structure of the ectodomain from HIV-1 gp41. Nature (1997) 16.31
Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature (1981) 15.85
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell (1991) 15.76
Structure of influenza haemagglutinin at the pH of membrane fusion. Nature (1994) 14.61
Structure of the human class I histocompatibility antigen, HLA-A2. Nature (1987) 14.54
A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science (1996) 12.64
Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science (1999) 12.52
The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature (1987) 12.43
The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature (1995) 12.25
The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem (1987) 11.99
A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature (1994) 11.50
Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. J Mol Biol (1993) 11.24
Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science (1998) 11.23
Printing proteins as microarrays for high-throughput function determination. Science (2000) 10.77
Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell (1997) 8.99
Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature (1993) 8.75
Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science (1995) 8.58
Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature (1988) 8.32
Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature (1983) 8.28
The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science (2004) 7.74
Three-dimensional structure of the tyrosine kinase c-Src. Nature (1997) 7.62
Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl Acad Sci U S A (1982) 7.34
Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature (1994) 7.13
The molecular basis of the specific anti-influenza action of amantadine. EMBO J (1985) 7.08
Control of p70 s6 kinase by kinase activity of FRAP in vivo. Nature (1995) 7.05
A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature (1989) 7.02
Controlling signal transduction with synthetic ligands. Science (1993) 6.70
Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc Natl Acad Sci U S A (1999) 6.50
The GCN4 basic region leucine zipper binds DNA as a dimer of uninterrupted alpha helices: crystal structure of the protein-DNA complex. Cell (1992) 6.47
Structural basis for the binding of proline-rich peptides to SH3 domains. Cell (1994) 6.34
Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell (1997) 6.27
Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature (1996) 6.20
Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature (1995) 6.16
A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature (1988) 5.99
Structure of simian virus 40 at 3.8-A resolution. Nature (1991) 5.96
Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP. Science (1996) 5.92
X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs. Proc Natl Acad Sci U S A (2001) 5.92
Rapamycin-modulated transcription defines the subset of nutrient-sensitive signaling pathways directly controlled by the Tor proteins. Proc Natl Acad Sci U S A (1999) 5.89
Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature (1998) 5.84
Crystalline antigen from the influenza virus envelope. Nat New Biol (1972) 5.77
Structure of an IkappaBalpha/NF-kappaB complex. Cell (1998) 5.67
DNA recognition by GAL4: structure of a protein-DNA complex. Nature (1992) 5.60
Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints. EMBO J (1998) 5.25
Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc Natl Acad Sci U S A (2000) 5.18
Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol Cell (1999) 5.09
HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc Natl Acad Sci U S A (1992) 5.02
Identification of self peptides bound to purified HLA-B27. Nature (1991) 4.88
Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell (1985) 4.84
Nucleotide sequences at the 5' termini of influenza virus RNAs and their transcripts. Nucleic Acids Res (1978) 4.83
Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol Cell (1998) 4.73
Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature (1990) 4.70
Recognition of a DNA operator by the repressor of phage 434: a view at high resolution. Science (1988) 4.60
Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. Science (1994) 4.57
Structure and mechanism of DNA topoisomerase II. Nature (1996) 4.56
PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints. Science (1995) 4.51
Retrovirus envelope domain at 1.7 angstrom resolution. Nat Struct Biol (1996) 4.49
Herpes simplex virus glycoprotein D bound to the human receptor HveA. Mol Cell (2001) 4.44
Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J Mol Biol (1991) 4.44
A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc Natl Acad Sci U S A (1984) 4.37
Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature (1989) 4.34
Structure of the reovirus core at 3.6 A resolution. Nature (2000) 4.28
Coiled coils in both intracellular vesicle and viral membrane fusion. Cell (1998) 4.26
Structure of PAK1 in an autoinhibited conformation reveals a multistage activation switch. Cell (2000) 4.21
Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA. Nature (1995) 4.08
Cytotoxic T cells to type A influenza virus; viral hemagglutinin induces A-strain specificity while infected cells confer cross-reactive cytotoxicity. Eur J Immunol (1977) 4.05
Transcription of the influenza virus genome. Virology (1977) 4.02
DNA arrangement in isometric phage heads. Nature (1977) 3.98
N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil. Proc Natl Acad Sci U S A (1999) 3.90
Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue. Proc Natl Acad Sci U S A (1995) 3.87
A role for histone deacetylase activity in HDAC1-mediated transcriptional repression. Proc Natl Acad Sci U S A (1998) 3.85
The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature (1991) 3.84
Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature (1992) 3.82
The polypeptide composition of influenza A viruses. Virology (1971) 3.79
Studies on the in vitro transcription of reovirus RNA catalyzed by reovirus cores. Virology (1969) 3.79
Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA. Nature (1998) 3.71
Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Proc Natl Acad Sci U S A (1990) 3.70
Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell (1998) 3.69
Diffraction methods for biological macromolecules. Oscillation method with large unit cells. Methods Enzymol (1985) 3.68
Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses. Nature (1977) 3.67
CoREST is an integral component of the CoREST- human histone deacetylase complex. Proc Natl Acad Sci U S A (2001) 3.66
Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature (1994) 3.60